Core Viewpoint - The company Di'an Diagnostics has announced the acquisition of a patent for a colorectal cancer detection biomarker, focusing on non-invasive urine sample testing, with commercialization currently in the early verification and technical assessment stage [1] Group 1: Patent and Technology - The patent titled "A Biomarker for Colorectal Cancer Detection and Its Application" was granted to Kailai Pu on October 3, 2025 [1] - The core technology involves a set of novel biomarkers for colorectal cancer detection, emphasizing convenience, non-invasiveness, and efficiency [1] Group 2: Commercialization Process - The company acknowledges that transitioning from patent authorization to a mature diagnostic product requires rigorous clinical validation, product development, and registration processes [1] - The company is committed to advancing the market application of this technology with a proactive and cautious approach [1]